[Cite as http://purl.org/au-research/grants/nhmrc/1053206]
A/Pr Michael Beard
Prof Gregory Dore
Prof Jacob George
Prof Andrew Lloyd
Brief description Hepatitis C affects a quarter of a million Australians, causing insidious but progressive liver disease which culminates in liver failure or cancer. There is no vaccine and prevention programs have limited effectiveness, but new antiviral therapies now offer high rates of cure. This Program will evaluate strategies to improve the health of those affected and prevent new infections by better understanding of the virus and the body’s immune response, including scarring and liver cancer formation.
Funding Amount $AUD 5,694,910.05
Funding Scheme Program Grants